Guaifenesin
NDC 0363-9569, Guaifenesin, tablet, from Walgreens.
- Product NDC
- 0363-9569
- Status
- Listed
- Labeler
- Walgreens
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA213420
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0363-9569 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN600 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0363-9569-02 | 00363956902 | 20 TABLET in 1 BLISTER PACK (0363-9569-02) |
| 0363-9569-04 | 00363956904 | 40 TABLET in 1 BLISTER PACK (0363-9569-04) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0363-9569 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0363-9569 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0363-9569. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.